Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Eukaryotic translation elongation factor 1 alpha 1 pseudogene 34 (EEF1A1P34)** is a processed pseudogene related to the protein-coding *EEF1A1* gene, which encodes a core translational elongation factor in the ribosome. Pseudogenes like EEF1A1P34 generally do not produce functional proteins and are not considered therapeutic targets. They are numerous in the human genome for this gene family and are mostly insufficiently characterized regarding their biological or disease relevance, although rare links to cancer phenotypes exist for some EEF1A1 pseudogenes[1][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation elongation factor 1 alpha 1 pseudogene 34 (EEF1A1P34).